173 related articles for article (PubMed ID: 23621748)
1. Crystal structure and enzymatic activity of an ADAMTS-13 mutant with the East Asian-specific P475S polymorphism.
Akiyama M; Nakayama D; Takeda S; Kokame K; Takagi J; Miyata T
J Thromb Haemost; 2013 Jul; 11(7):1399-406. PubMed ID: 23621748
[TBL] [Abstract][Full Text] [Related]
2. The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico study.
Lancellotti S; Peyvandi F; Pagliari MT; Cairo A; Abdel-Azeim S; Chermak E; Lazzareschi I; Mastrangelo S; Cavallo L; Oliva R; De Cristofaro R
Thromb Haemost; 2016 Jan; 115(1):51-62. PubMed ID: 26272487
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor.
Akiyama M; Takeda S; Kokame K; Takagi J; Miyata T
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19274-9. PubMed ID: 19880749
[TBL] [Abstract][Full Text] [Related]
4. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
Kokame K
Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
[TBL] [Abstract][Full Text] [Related]
5. Structure-function and regulation of ADAMTS-13 protease.
Zheng XL
J Thromb Haemost; 2013 Jun; 11 Suppl 1(0 1):11-23. PubMed ID: 23809107
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS-13 regulates platelet adhesion under flow. A new method for differentiation between inherited and acquired thrombotic thrombocytopenic purpura.
Shenkman B; Budde U; Angerhaus D; Lubetsky A; Savion N; Seligsohn U; Varon D
Thromb Haemost; 2006 Aug; 96(2):160-6. PubMed ID: 16894459
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
Zhou Z; Nguyen TC; Guchhait P; Dong JF
Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
[TBL] [Abstract][Full Text] [Related]
8. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.
Dong JF; Moake JL; Nolasco L; Bernardo A; Arceneaux W; Shrimpton CN; Schade AJ; McIntire LV; Fujikawa K; López JA
Blood; 2002 Dec; 100(12):4033-9. PubMed ID: 12393397
[TBL] [Abstract][Full Text] [Related]
9. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.
Kokame K; Matsumoto M; Soejima K; Yagi H; Ishizashi H; Funato M; Tamai H; Konno M; Kamide K; Kawano Y; Miyata T; Fujimura Y
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11902-7. PubMed ID: 12181489
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic thrombocytopenic purpura and anti-thrombotic therapy targeted to von Willebrand factor.
Zhou Z; Dong JF
Curr Vasc Pharmacol; 2012 Nov; 10(6):762-6. PubMed ID: 22022775
[TBL] [Abstract][Full Text] [Related]
11. [New marker in thrombotic thrombocytopenic purpura].
Gøtze JP; Hillarp A; Lindblom A; Björk P; Strandberg K; Nielsen LB
Ugeskr Laeger; 2008 Aug; 170(33):2446-9. PubMed ID: 18761827
[TBL] [Abstract][Full Text] [Related]
12. The novel ADAMTS13-p.D187H mutation impairs ADAMTS13 activity and secretion and contributes to thrombotic thrombocytopenic purpura in mice.
De Cock E; Hermans C; De Raeymaecker J; De Ceunynck K; De Maeyer B; Vandeputte N; Vandenbulcke A; Deckmyn H; Rottensteiner H; De Maeyer M; De Meyer SF; Vanhoorelbeke K
J Thromb Haemost; 2015 Feb; 13(2):283-92. PubMed ID: 25442981
[TBL] [Abstract][Full Text] [Related]
13. Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.
Jin SY; Skipwith CG; Zheng XL
Blood; 2010 Mar; 115(11):2300-10. PubMed ID: 20075158
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura.
Camilleri RS; Cohen H; Mackie IJ; Scully M; Starke RD; Crawley JT; Lane DA; Machin SJ
J Thromb Haemost; 2008 Feb; 6(2):331-8. PubMed ID: 18031293
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic thrombocytopenic purpura.
Lämmle B; Kremer Hovinga JA; Alberio L
J Thromb Haemost; 2005 Aug; 3(8):1663-75. PubMed ID: 16102032
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate.
Cruz MA; Whitelock J; Dong JF
Thromb Haemost; 2003 Dec; 90(6):1204-9. PubMed ID: 14652658
[TBL] [Abstract][Full Text] [Related]
17. Conformational activation of ADAMTS13.
South K; Luken BM; Crawley JT; Phillips R; Thomas M; Collins RF; Deforche L; Vanhoorelbeke K; Lane DA
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18578-83. PubMed ID: 25512499
[TBL] [Abstract][Full Text] [Related]
18. Disulfide bond reduction of von Willebrand factor by ADAMTS-13.
Yeh HC; Zhou Z; Choi H; Tekeoglu S; May W; Wang C; Turner N; Scheiflinger F; Moake JL; Dong JF
J Thromb Haemost; 2010 Dec; 8(12):2778-88. PubMed ID: 20946172
[TBL] [Abstract][Full Text] [Related]
19. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13.
Kokame K; Matsumoto M; Fujimura Y; Miyata T
Blood; 2004 Jan; 103(2):607-12. PubMed ID: 14512308
[TBL] [Abstract][Full Text] [Related]
20. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Tsai HM
J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
